These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32381178)

  • 41. The Role of Necroptosis in Cardiovascular Disease.
    Zhe-Wei S; Li-Sha G; Yue-Chun L
    Front Pharmacol; 2018; 9():721. PubMed ID: 30034339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dichotomy between Receptor-Interacting Protein 1- and Receptor-Interacting Protein 3-Mediated Necroptosis in Experimental Pancreatitis.
    Wu J; Mulatibieke T; Ni J; Han X; Li B; Zeng Y; Wan R; Wang X; Hu G
    Am J Pathol; 2017 May; 187(5):1035-1048. PubMed ID: 28315674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The protective effect of DNA aptamer on osteonecrosis of the femoral head by alleviating TNF-α-mediated necroptosis via RIP1/RIP3/MLKL pathway.
    Fan X; Xu X; Wu X; Xia R; Gao F; Zhang Q; Sun W
    J Orthop Translat; 2022 Sep; 36():44-51. PubMed ID: 35919280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of MLKL Oligomerization During Programmed Necrosis.
    Cai Z; Liu ZG
    Methods Mol Biol; 2018; 1857():85-92. PubMed ID: 30136232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kinases control of regulated cell death revealing druggable targets for Parkinson's disease.
    Mansour HM; Mohamed AF; El-Khatib AS; Khattab MM
    Ageing Res Rev; 2023 Mar; 85():101841. PubMed ID: 36608709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Initiation and execution mechanisms of necroptosis: an overview.
    Grootjans S; Vanden Berghe T; Vandenabeele P
    Cell Death Differ; 2017 Jul; 24(7):1184-1195. PubMed ID: 28498367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases.
    Zhang Q; Hu XM; Zhao WJ; Ban XX; Li Y; Huang YX; Wan H; He Y; Liao LS; Shang L; Jiang B; Qing GP; Xiong K
    Int J Biol Sci; 2023; 19(2):658-674. PubMed ID: 36632450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives.
    Zhuang C; Chen F
    J Med Chem; 2020 Feb; 63(4):1490-1510. PubMed ID: 31622096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A cytosolic heat shock protein 90 and cochaperone CDC37 complex is required for RIP3 activation during necroptosis.
    Li D; Xu T; Cao Y; Wang H; Li L; Chen S; Wang X; Shen Z
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5017-22. PubMed ID: 25852146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mixed lineage kinase domain-like protein induces RGC-5 necroptosis following elevated hydrostatic pressure.
    Liao L; Shang L; Li N; Wang S; Wang M; Huang Y; Chen D; Huang J; Xiong K
    Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):879-889. PubMed ID: 28981598
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repurposing anticancer drugs for targeting necroptosis.
    Fulda S
    Cell Cycle; 2018; 17(7):829-832. PubMed ID: 29464983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uncovering human mixed lineage kinase domain-like activation in necroptosis.
    Guibao CD; Petrinjak K; Moldoveanu T
    Future Med Chem; 2019 Nov; 11(21):2831-2844. PubMed ID: 31713433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coordinated ubiquitination and phosphorylation of RIP1 regulates necroptotic cell death.
    de Almagro MC; Goncharov T; Izrael-Tomasevic A; Duttler S; Kist M; Varfolomeev E; Wu X; Lee WP; Murray J; Webster JD; Yu K; Kirkpatrick DS; Newton K; Vucic D
    Cell Death Differ; 2017 Jan; 24(1):26-37. PubMed ID: 27518435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RIPK1/RIPK3/MLKL-mediated necroptosis contributes to compression-induced rat nucleus pulposus cells death.
    Chen S; Lv X; Hu B; Shao Z; Wang B; Ma K; Lin H; Cui M
    Apoptosis; 2017 May; 22(5):626-638. PubMed ID: 28289909
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulated Necrosis in Pulmonary Disease. A Focus on Necroptosis and Ferroptosis.
    Minagawa S; Yoshida M; Araya J; Hara H; Imai H; Kuwano K
    Am J Respir Cell Mol Biol; 2020 May; 62(5):554-562. PubMed ID: 32017592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cisplatin-induced necroptosis in TNFα dependent and independent pathways.
    Xu Y; Ma HB; Fang YL; Zhang ZR; Shao J; Hong M; Huang CJ; Liu J; Chen RQ
    Cell Signal; 2017 Feb; 31():112-123. PubMed ID: 28065786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ATP-Competitive MLKL Binders Have No Functional Impact on Necroptosis.
    Ma B; Marcotte D; Paramasivam M; Michelsen K; Wang T; Bertolotti-Ciarlet A; Jones JH; Moree B; Butko M; Salafsky J; Sun X; McKee T; Silvian LF
    PLoS One; 2016; 11(11):e0165983. PubMed ID: 27832137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Necroptosis-independent signaling by the RIP kinases in inflammation.
    Moriwaki K; Chan FK
    Cell Mol Life Sci; 2016 Jun; 73(11-12):2325-34. PubMed ID: 27048814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD.
    Chen H; Fang Y; Wu J; Chen H; Zou Z; Zhang X; Shao J; Xu Y
    Cell Death Dis; 2018 Aug; 9(9):878. PubMed ID: 30158627
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.
    Hänggi K; Vasilikos L; Valls AF; Yerbes R; Knop J; Spilgies LM; Rieck K; Misra T; Bertin J; Gough PJ; Schmidt T; de Almodòvar CR; Wong WW
    Cell Death Dis; 2017 Feb; 8(2):e2588. PubMed ID: 28151480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.